ReleaseWire Connect

Amyloid Precursor Protein (APP) - Pipeline Review, H2 2016', provides in depth analysis on Amyloid Precursor Protein (APP) targeted pipeline therapeutics, the report provides comprehensive information on the Amyloid Precursor Protein (APP), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Amyloid Precursor Protein (APP) targeted therapeutics development and features dormant and discontinued projects.

'Medullary Thyroid Cancer - Pipeline Review, H2 2016', provides an overview of the Medullary Thyroid Cancer pipeline landscape, the report provides comprehensive information on the therapeutics under development for Medullary Thyroid Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Medullary Thyroid Cancer and features dormant and discontinued projects.

'Anal Cancer - Pipeline Review, H2 2016', provides an overview of the Anal Cancer pipeline landscape, the report provides comprehensive information on the therapeutics under development for Anal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects.

Fecal occult testing is simple and non-invasive in nature, thereby increasing its preference among many physicians. The results of few of the fecal occult tests can be obtained rapidly through point-of-care (POC) test kits such as Alere's Clearview iFOB, and Beckman Coulter's Hemoccult II SENSA. For instance, the Clearview iFOB test is based on human hemoglobin and gastrointestinal bleeding, and can provide results in five minutes. Beckman Coulter's Hemoccult II SENSA slides allow people to collect fecal samples at home settings and send them to hospitals, laboratories, and diagnostic centers.

Hearing aid amplifies the sound volume and improves sound perception to support people with hearing impairment but does not restore the normal functioning of the ear. The device has three basic components: microphone, amplifier, and speaker. The microphone of a hearing aid receives and converts sound waves into electrical signals. An amplifier increases the power of these signals and sends them to the ear through a speaker.

Urinary catheters are hollow, partially flexible tubes that help collect urine from the bladder. These devices are attached to a drainage bag that collect the urine. They are available in the market in the forms of rubber, plastic, silicone, or latex. The catheter tube is attached to a drainage bag that holds the collected urine. These catheters can be used permanently or temporarily depending on the individuals' health condition.

NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.

Dental services include medical and cosmetic procedures for oral cavity, dental implants to restore facial structure, dental crowns to protect damaged teeth, and treatment options for dental diseases.

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.

The global angioplasty balloon market presents significant opportunities for vendors to grow in untapped countries, particularly those in APAC. The market is highly dynamic and characterized by intense competition, with the presence of many global and local players that develop safe, easy-to-use, cost-effective, and widely available products in the market. These companies adopt creative strategies and develop innovative devices to ensure product differentiation. In 2015, Medtronic, Abbott Laboratories, Boston Scientific, and C. R. Bard were the leading vendors in the market.